Coagulo is leading the evolution of personalized coagulation management with the introduction of the world’s first precision-medicine platform capable of pinpointing abnormalities across the entire clotting cascade and delivering clinically-valuable information that no other technology provides.
Location: United States, Massachusetts
Employees: 1-10
Founded date: 2018
Investors 3
Mentions in press and media 1
| Date | Title | Description |
| 22.12.2020 | Coagulo Medical Technologies : Announces $6.5 Million in Financing to Accelerate Delivery of Disruptive Coagulation Diagnostics Platform | Coagulo Medical Technologies, an MIT-born startup that has developed the world’s first precision-medicine platform for comprehensive and targeted blood clotting management, today announced it has raised $6.5 million in financing from 20/20 ... |